Table 1. Prognosis value of core circadian genes in STAD.

Genes	Overall Survival		Progression Free Survival		Disease Free Survival
	p-value	HR (95% CI)	p-value	HR (95% CI)	p-value	HR (95% CI)
CLOCK	0.308	1.19 (0.85–1.65)	0.700	0.93 (0.66–1.33)	0.791	0.95 (0.62–1.43)
ARNTL	0.391	1.15 (0.83–1.60)	0.300	1.21 (0.85–1.72)	0.305	1.25 (0.82–1.89)
CRY1	0.207	0.81 (0.58–1.12)	0.634	0.92 (0.65–1.31)	0.689	0.92 (0.61–1.39)
CRY2	0.073	1.35 (0.97–1.89)	0.380	1.17 (0.82–1.67)	0.028	1.62 (1.05–2.49)
NR1D1	0.002	1.69 (1.21–2.36)	0.008	1.62 (1.13–2.31)	0.002	1.96 (1.27–3.02)
PER1	0.007	1.59 (1.14–2.22)	0.007	1.64 (1.14–2.35)	0.010	1.69 (1.10–2.60)
PER2	0.701	0.94 (0.68–1.30)	0.903	0.98 (0.69–1.39)	0.590	1.12 (0.74–1.71)
PER3	0.440	1.14 (0.82–1.58)	0.107	1.34 (0.94–1.92)	0.127	1.39 (0.91–2.12)
RORA	0.143	1.28 (0.92–1.77)	0.078	1.38 (0.96–1.96)	0.092	1.43 (0.94–2.18)